World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 1254707

Number of visits today: 699

Number of downloads: 828498

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Manley BJ, Kim EH, Vetter JM, Potretzke AM, Strope SA. Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA. Int Braz J Urol 2017;43:432-9. [PMID: 28128914 DOI: 10.1590/S1677-5538.IBJU.2015.0118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]

For:

Manley BJ, Kim EH, Vetter JM, Potretzke AM, Strope SA. Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA. Int Braz J Urol 2017;43:432-9. [PMID: 28128914 DOI: 10.1590/S1677-5538.IBJU.2015.0118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]

Number	Citing Articles
1	Shapiro DD, Abel EJ. Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors. Current Opinion in Urology 2019;29:513-20. [DOI: 10.1097/mou.0000000000000658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2	Hsiang WR, Kenney PA, Leapman MS. Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma. Curr Oncol Rep 2020;22:35. [PMID: 32170461 DOI: 10.1007/s11912-020-0895-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3	Zhao K, Kim EH, Vetter JM, Hsieh JJ, Venkatesh R, Bhayani SB, Figenshau RS. Laparoscopic cytoreductive nephrectomy is associated with significantly improved survival compared with open cytoreductive nephrectomy or targeted therapy alone. Mol Clin Oncol 2020;13:71. [PMID: 33005405 DOI: 10.3892/mco.2020.2141] [Reference Citation Analysis]
4	Shapiro DD, Westerman ME, Karam JA, Wood CG. Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question? Cancer J 2020;26:382-9. [PMID: 32947306 DOI: 10.1097/PPO.0000000000000470] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5	Esagian SM, Ziogas IA, Kosmidis D, Hossain MD, Tannir NM, Msaouel P. Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis. Cancers (Basel) 2021;13:695. [PMID: 33572149 DOI: 10.3390/cancers13040695] [Reference Citation Analysis]